Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer
Checkpoint Therapeutics to Participate in the B. Riley Securities’ 3rd Annual Oncology Conference
Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
Stay informed and receive company updates straight to your inbox.